We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 1.47% | 69.00 | 68.00 | 70.00 | 69.00 | 68.00 | 68.00 | 34,583 | 09:52:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -5.26 | 16.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/5/2024 10:31 | The MMs do love their delayed trades in NSCI! | loafofbread | |
15/5/2024 19:32 | NAV is £44M vs £15M MCap I think the risk/reward is as good as it gets. Glycotest is valued in the books at £11M and we are finally close to a read out. Could be worth £5M or £50M if the test works and Fosan want full control. ProAxis worth £8M. since then received another £500K in funding grants. Might go for £10M/£15M with a fair wind. Downside fully protected but upside is potentially massive. | loafofbread | |
14/5/2024 13:21 | Vox interview much better than yesterdays Proactive effort. Clear explanation of what's to come and how this is a win win for NSCI shareholders. | loafofbread | |
14/5/2024 10:49 | So much going on but nothing being reflected in the share price! | blakieboy7 | |
14/5/2024 10:31 | NetScientific Q&A: "we're right in the middle of the action of venture capital" | sev22 | |
13/5/2024 22:13 | hTtps://stkt.co/Z4P0 | blakieboy7 | |
13/5/2024 20:37 | Today's news was hugely significant I suspect we will kick on from here in my opinion | senttothegallows | |
13/5/2024 19:49 | Could also do with some Simon Thompson PR | blakieboy7 | |
13/5/2024 11:35 | great points. think results are due imminently - perhaps there'll be some positive narrative to expand on the recent raft of good news which stirs up the wider markets. | mortimer7 | |
13/5/2024 11:18 | Yet again completely ignored by the wider market. M7, I think the ProAxis value uplift from £3.5M to £8M+ might have had you opening that drawer a few weeks ago. They won another £500K grant last week. The sooner the company starts a share buy back to narrow the discount to NAV the better. Once they have closed the gap somewhat they can invest elsewhere! | loafofbread | |
13/5/2024 10:59 | NetScientific CEO hails deal with Martlet Capital as an important milestone. | sev22 | |
13/5/2024 09:25 | Having had these in the bottom drawer for years, this is finally an RNS that may have a significant positive bearing. | mortimer7 | |
13/5/2024 08:41 | Fund management is a lucrative business. Moreover, this transaction will widen the network of accessing to exciting early stage investments. There may be a blockbuster amongst them. | kingston78 | |
13/5/2024 07:48 | Fantastic RNS transformational in my opinion | senttothegallows | |
10/5/2024 09:56 | Has gone NT to buy at 65p on just a few small buys. | z1co | |
10/5/2024 09:31 | Utter rubbish being posted here. Pdsb released news very late last night from then Nsci have to get their nomad to approve and post. Nsci unlikely to move as it seems holders and the market are unable to grasp the value in something where assets are more than 3 times the share price. Ultimately good news at pdsb | senttothegallows | |
10/5/2024 09:13 | Finally woken up at HQ? | loafofbread | |
10/5/2024 09:12 | Looks like ProAxis won another £500k grant yesterday. Not bad going and will help with the sale process. | loafofbread | |
10/5/2024 08:03 | Maybe we can expect an RNS once the US markets open | blakieboy7 | |
10/5/2024 07:12 | No 7am RNS ! Typical of NSCI | blakieboy7 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions